WORLDWIDE‑CORRUPTION

Peru · Findings · Debarred / sanctioned abroad × US SEC issuer

BMY · SUB~ · PE · BRISTOL-MYERS SQUIBB PERU SA - PERUFARMA SA

Why it is here

Indicator “Debarred / sanctioned abroad × US SEC issuer”: looks like a subsidiary 'BRISTOL MYERS SQUIBB A ~0.80' «BRISTOL-MYERS SQUIBB PERU SA - PERUFARMA SA» ↔ SEC BMY (CIK 14272, BRISTOL MYERS SQUIBB CO): 2 non-competitive contracts at the buyer «SEGURO SOCIAL DE SALUD», 968,959 PEN (≈ $261,619); one bid, method direct (Contratación Directa); OCID ocds-dgv273-seacev3-842780, ocds-dgv273-seacev3-1032349; ⚑ REPEAT: already sanctioned SEC by FCPA (2015-10-05 Bristol-Myers Squibb).

Indicators computed from public data sets: contracts, payments, registers, trade and sanctions lists. An indicator is a reason to check, not a decision of a public authority.

Details

Company / subject
BMY · SUB~ · PE · BRISTOL-MYERS SQUIBB PERU SA - PERUFARMA SA
Indicator
Debarred / sanctioned abroad × US SEC issuer
Amount
261,619
Records behind the indicator
2
Found
4 October 2026
Code
W-02236
Reference
ocds-dgv273-seacev3-842780
Reference
ocds-dgv273-seacev3-1032349
Reference
2015-10-05

Other records of this company3

  1. 014 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
  2. 024 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer
  3. 034 October 2026Findings · Debarred / sanctioned abroad × US SEC issuer

JSONFindings · Debarred / sanctioned abroad × US SEC issuer